Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Youngstown › NPI 1548296106
Hospital

Mercy Health Youngstown LLC

Mercy Health Youngstown LLC was paid $63.87M by Medicaid between Jan 2018 and Dec 2024, across 512 billing codes. Its largest line is 99283, emergency room visit (moderate) — 15% of everything it billed.

33Billing provider infoMERCY HEALTH YOUNGSTOWN LLC
YOUNGSTOWN, OH 44504
33aNPI1548296106assigned 06/24/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$63.87M
24GClaims1,956,028
24DCodes billed512
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Psychiatric Hospital Unit providers in Ohio

Rank by total paid#1 of 6
Median peer was paid$22.82M
This provider vs. median2.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018175,523$5.13M
2019206,321$6.17M
2020181,554$7.38M
2021179,768$6.94M
2022220,310$7.40M
2023567,612$17.63M
2024incomplete424,940$13.21M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 15% 81,708 76,735 $9.34M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 14% 72,558 65,133 $8.75M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 10% 81,939 71,497 $6.58M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.3% 44,229 38,019 $5.96M
70450 Computed tomography, head or brain; without contrast material 7.8% 20,282 17,909 $4.99M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.5% 11,545 9,999 $2.88M
96361 Intravenous infusion, hydration; each additional hour 2.8% 5,684 4,122 $1.81M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.8% 20,119 19,160 $1.80M
80053 Comprehensive metabolic panel 2.7% 142,769 121,515 $1.72M
71275 Computed tomographic angiography, chest, with contrast material 1.5% 3,498 2,976 $929K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.4% 3,649 3,123 $923K
G0378 Hospital observation service, per hour 1.1% 10,873 4,332 $727K
500 more codes
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 5,643 $614K
84443 Thyroid stimulating hormone (TSH) <1% 29,505 $581K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,231 $578K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 1,406 $549K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 2,256 $535K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 4,051 $523K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 7,403 $522K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 4,547 $469K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 143,745 $464K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 7,955 $444K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 4,022 $359K
80061 Lipid panel <1% 29,132 $358K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 3,932 $342K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,724 $298K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 4,993 $292K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 20,906 $268K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 12,182 $257K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 558 $210K
83036 Hemoglobin; glycosylated (A1C) <1% 18,145 $188K
80048 Basic metabolic panel (calcium, ionized) <1% 26,244 $188K
83605 <1% 38,124 $185K
H2020 Therapeutic behavioral services, per diem <1% 1,279 $182K
36415 Collection of venous blood by venipuncture <1% 127,953 $171K
70496 <1% 652 $169K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,760 $167K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 10,184 $167K
70491 <1% 556 $165K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 1,343 $164K
84484 <1% 47,595 $158K
93017 <1% 1,811 $151K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,633 $143K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 830 $143K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 12,738 $142K
84439 <1% 8,954 $141K
11045 <1% 377 $134K
76642 <1% 1,079 $129K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,934 $128K
85027 <1% 21,017 $128K
71046 Radiologic examination, chest; 2 views <1% 18,133 $123K
93458 <1% 150 $123K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 54,635 $120K
S9472 Cardiac rehabilitation program, non-physician provider, per diem <1% 1,442 $117K
80320 <1% 8,688 $109K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 2,186 $108K
93798 <1% 1,809 $108K
71045 Radiologic examination, chest; single view <1% 29,423 $104K
72131 <1% 1,782 $97K
71250 <1% 1,323 $96K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 451 $93K
93970 <1% 654 $92K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,977 $91K
77334 <1% 264 $90K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 925 $86K
97161 <1% 1,831 $86K
99213 Doctor's office visit, returning patient (routine) <1% 954 $83K
12001 <1% 532 $81K
93971 <1% 1,347 $79K
72125 Computed tomography, cervical spine; without contrast material <1% 7,435 $78K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 913 $78K
82607 <1% 5,198 $77K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,934 $73K
86900 <1% 3,832 $67K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 47,675 $65K
82728 <1% 3,380 $62K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 460 $62K
71271 <1% 466 $62K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,781 $61K
95911 <1% 246 $59K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 484 $59K
77336 <1% 695 $57K
86803 <1% 2,525 $57K
10060 <1% 335 $54K
G0382 Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 644 $54K
93975 <1% 625 $53K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 123 $53K
97165 <1% 1,135 $52K
70551 Magnetic resonance imaging, brain; without contrast material <1% 367 $52K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,233 $50K
41899 Unlisted procedure, dentoalveolar structures <1% 102 $50K
95886 <1% 856 $49K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 4,846 $47K
76830 Ultrasound, transvaginal <1% 872 $46K
94060 <1% 548 $46K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,803 $45K
86850 <1% 3,540 $45K
76536 <1% 473 $45K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 1,270 $44K
87088 <1% 7,463 $42K
86140 <1% 4,707 $42K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 36,507 $42K
81001 <1% 51,729 $42K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 440 $42K
96367 <1% 738 $40K
76770 <1% 281 $40K
83880 <1% 9,533 $39K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,516 $39K
73700 <1% 357 $38K
90853 Group psychotherapy (other than of a multiple-family group) <1% 1,599 $36K
83540 <1% 3,524 $36K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,871 $36K
83735 <1% 13,749 $35K
A0426 Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) <1% 763 $35K
70498 <1% 591 $34K
87081 <1% 1,834 $33K
86038 <1% 1,362 $32K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,907 $32K
88142 <1% 1,755 $32K
95913 <1% 127 $31K
86703 <1% 1,123 $30K
97014 <1% 1,044 $29K
82746 <1% 4,017 $29K
84153 <1% 1,583 $29K
96375 Therapeutic injection; each additional sequential IV push <1% 29,811 $29K
90714 <1% 1,909 $28K
87070 <1% 2,546 $28K
A0428 Ambulance service, basic life support, non-emergency transport, (bls) <1% 516 $27K
94729 <1% 404 $27K
83550 <1% 3,080 $26K
72128 <1% 721 $26K
70486 <1% 989 $26K
12002 <1% 170 $26K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,591 $25K
82570 <1% 2,950 $25K
93308 <1% 144 $25K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 710 $25K
77066 Tomosynthesis, mammo <1% 711 $25K
74174 <1% 111 $24K
72100 <1% 1,443 $24K
86592 <1% 1,509 $24K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 49 $24K
83970 <1% 1,000 $24K
83516 <1% 902 $23K
74018 <1% 773 $23K
83690 <1% 26,608 $23K
J0897 Injection, denosumab, 1 mg <1% 25 $23K
P9016 Red blood cells, leukocytes reduced, each unit <1% 81 $22K
73130 <1% 2,398 $22K
85610 <1% 8,790 $22K
82805 <1% 697 $21K
96415 <1% 212 $21K
73030 <1% 2,341 $21K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,386 $21K
93880 <1% 318 $20K
77065 Tomosynthesis, mammo <1% 611 $20K
73630 <1% 2,571 $20K
73502 <1% 1,530 $19K
73562 <1% 1,674 $19K
84702 <1% 1,872 $19K
94726 <1% 297 $19K
87077 <1% 2,521 $19K
72141 <1% 135 $19K
80076 <1% 1,644 $19K
87340 <1% 1,105 $19K
12011 <1% 128 $19K
73610 <1% 3,244 $18K
97535 Self-care/home management training, each 15 minutes <1% 824 $18K
74178 <1% 65 $17K
80346 <1% 894 $17K
A0425 Ground mileage, per statute mile <1% 1,476 $17K
80074 <1% 874 $17K
90677 <1% 71 $17K
84403 <1% 809 $17K
90686 <1% 1,130 $17K
93923 <1% 238 $16K
72040 <1% 532 $16K
73560 <1% 1,507 $16K
84550 <1% 2,214 $15K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 59 $15K
86901 <1% 3,792 $15K
86039 <1% 885 $15K
20610 <1% 97 $14K
80143 <1% 8,775 $14K
86787 <1% 580 $14K
86431 <1% 818 $14K
85652 <1% 2,985 $14K
87522 Neg quan hep c or qual rna <1% 390 $13K
82077 <1% 5,231 $13K
81003 <1% 9,459 $13K
84146 <1% 619 $12K
80164 <1% 1,370 $12K
77300 <1% 62 $12K
83001 <1% 590 $12K
87210 <1% 1,620 $11K
96376 <1% 3,547 $11K
86403 <1% 683 $11K
86762 <1% 550 $11K
84630 <1% 709 $11K
85378 <1% 3,143 $11K
80364 <1% 976 $11K
82962 <1% 8,622 $10K
88112 <1% 411 $10K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 109 $10K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 1,090 $10K
36591 <1% 424 $10K
85651 <1% 1,838 $10K
90832 Psychotherapy session, about 30 minutes <1% 123 $10K
88304 <1% 585 $10K
73590 <1% 1,395 $9K
82043 <1% 1,674 $9K
84100 <1% 2,740 $9K
86317 <1% 513 $9K
82525 <1% 459 $9K
49083 <1% 23 $9K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 3,090 $9K
82550 <1% 3,655 $9K
84481 <1% 666 $9K
84425 <1% 768 $9K
C8908 Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral <1% 28 $9K
84270 <1% 477 $8K
73110 <1% 1,428 $8K
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 602 $8K
82044 <1% 986 $8K
86481 <1% 234 $8K
82784 <1% 843 $8K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,633 $8K
81002 <1% 7,297 $8K
J2469 Injection, palonosetron hcl, 25 mcg <1% 544 $8K
80179 <1% 8,757 $7K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 408 $7K
36430 <1% 92 $7K
82670 <1% 278 $7K
86376 <1% 400 $7K
87186 <1% 1,180 $7K
82248 <1% 2,025 $7K
83002 <1% 426 $7K
86003 <1% 340 $7K
84134 <1% 591 $7K
82533 <1% 401 $7K
72110 <1% 206 $7K
73552 <1% 896 $7K
87040 <1% 3,764 $7K
64415 <1% 38 $6K
84703 <1% 6,425 $6K
90715 <1% 429 $6K
86706 <1% 277 $6K
78815 Positron emission tomography (PET) for limited area imaging <1% 15 $6K
92523 <1% 101 $6K
86704 <1% 323 $6K
87205 <1% 1,872 $6K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 515 $6K
88307 <1% 101 $5K
86200 <1% 315 $5K
84520 <1% 741 $5K
84480 <1% 413 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,918 $5K
84590 <1% 425 $5K
83695 <1% 400 $5K
82140 <1% 823 $5K
G0008 Administration of influenza virus vaccine <1% 1,282 $5K
82105 <1% 378 $4K
81025 <1% 10,456 $4K
73564 <1% 484 $4K
76641 <1% 33 $4K
84156 <1% 820 $4K
86255 <1% 182 $4K
95912 <1% 13 $4K
90791 Psychiatric diagnostic evaluation <1% 32 $4K
76981 <1% 48 $4K
73080 <1% 544 $4K
82565 <1% 861 $4K
84436 <1% 1,091 $4K
82947 <1% 1,061 $4K
72120 <1% 106 $4K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 542 $4K
86618 <1% 239 $4K
93922 <1% 57 $4K
97597 <1% 30 $4K
86235 <1% 197 $4K
92526 <1% 83 $4K
85730 <1% 2,786 $4K
73521 <1% 218 $3K
76870 <1% 82 $3K
J3490 Unclassified drugs <1% 133 $3K
90935 Hemodialysis procedure with single evaluation by a physician <1% 20 $3K
72050 <1% 93 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 5,428 $3K
72170 <1% 898 $3K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 20 $3K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 34 $3K
86225 <1% 175 $3K
86923 <1% 118 $3K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 5,754 $3K
73090 <1% 637 $3K
77080 <1% 47 $3K
88342 <1% 610 $3K
73070 <1% 350 $3K
J1953 Injection, levetiracetam, 10 mg <1% 683 $3K
83615 <1% 440 $3K
85379 <1% 3,017 $3K
94250 <1% 32 $3K
83520 <1% 85 $2K
87075 <1% 684 $2K
95910 <1% 15 $2K
83655 <1% 115 $2K
97022 <1% 36 $2K
99203 Doctor's office visit, new patient (routine) <1% 63 $2K
80349 <1% 186 $2K
74183 <1% 13 $2K
82785 <1% 158 $2K
J1650 Injection, enoxaparin sodium, 10 mg <1% 3,490 $2K
95816 <1% 12 $2K
72072 <1% 121 $2K
76801 <1% 64 $2K
73060 <1% 396 $2K
73221 <1% 14 $2K
80178 <1% 193 $2K
86308 <1% 535 $2K
87147 <1% 150 $2K
97129 <1% 59 $2K
94010 <1% 202 $2K
90648 <1% 209 $2K
95117 <1% 84 $2K
84165 <1% 205 $2K
81005 <1% 302 $2K
71101 <1% 218 $2K
96368 <1% 268 $2K
84145 <1% 530 $2K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 13 $2K
S9445 Patient education, not otherwise classified, non-physician provider, individual, per session <1% 28 $2K
81170 <1% 14 $1K
78306 <1% 15 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 30,511 $1K
85014 <1% 485 $1K
88185 <1% 21 $1K
86256 <1% 74 $1K
82150 <1% 1,419 $1K
82977 <1% 176 $1K
82950 <1% 94 $1K
86160 <1% 97 $1K
86800 <1% 81 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 5,040 $1K
94664 <1% 940 $1K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 88 $1K
81206 <1% 12 $1K
82627 <1% 55 $1K
J3486 Injection, ziprasidone mesylate, 10 mg <1% 100 $1K
99214 Doctor's office visit, returning patient (more involved) <1% 14 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,090 $1K
90670 <1% 223 $1K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 14 $1K
84132 <1% 842 $1K
80177 <1% 111 $965.49
87449 <1% 150 $928.78
80202 <1% 45 $887.58
86334 <1% 61 $880.65
80353 <1% 75 $852.16
82951 <1% 32 $833.64
72070 <1% 18 $827.33
93325 <1% 15 $820.57
82378 <1% 122 $809.40
J1644 Injection, heparin sodium, per 1000 units <1% 2,252 $808.70
87045 <1% 68 $786.46
74022 <1% 73 $777.55
87634 <1% 754 $761.33
00170 Anesthesia for intraoral procedures, including biopsy <1% 424 $746.38
82103 <1% 57 $724.85
82553 <1% 69 $699.22
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 368 $683.74
84155 <1% 127 $681.81
80373 <1% 59 $667.81
85018 <1% 366 $665.52
97130 <1% 41 $662.32
80323 <1% 40 $659.75
90633 <1% 75 $653.80
80162 <1% 40 $624.53
84478 <1% 128 $619.72
82465 <1% 69 $616.36
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 543 $615.37
J0360 Injection, hydralazine hcl, up to 20 mg <1% 665 $595.07
J1170 Injection, hydromorphone, up to 4 mg <1% 989 $565.16
84466 <1% 74 $550.98
82010 <1% 693 $549.40
80050 General health panel <1% 312 $542.39
84460 <1% 68 $533.82
J1453 Injection, fosaprepitant, 1 mg <1% 45 $532.50
88184 <1% 12 $528.95
86735 <1% 18 $528.21
85045 <1% 138 $521.54
80347 <1% 32 $514.35
J7030 Infusion, normal saline solution , 1000 cc <1% 1,312 $512.73
76775 <1% 13 $508.48
G0009 Administration of pneumococcal vaccine <1% 271 $504.68
86880 <1% 29 $503.28
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 1,757 $498.72
90723 <1% 129 $483.30
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 873 $474.13
G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) <1% 15 $467.21
86765 <1% 21 $433.81
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 5,201 $423.30
82330 <1% 35 $418.24
J2310 Injection, naloxone hydrochloride, per 1 mg <1% 34 $394.59
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 17,321 $390.94
87046 <1% 66 $387.43
J2704 Injection, propofol, 10 mg <1% 7,868 $372.79
00731 <1% 336 $372.09
J3010 Injection, fentanyl citrate, 0.1 mg <1% 7,581 $371.03
00813 <1% 145 $359.26
00811 <1% 31 $359.26
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,017 $347.77
J0690 Injection, cefazolin sodium, 500 mg <1% 3,215 $338.84
73120 <1% 13 $335.32
90681 <1% 37 $311.60
87427 <1% 53 $310.20
J2060 Injection, lorazepam, 2 mg <1% 1,817 $296.72
83525 <1% 18 $295.02
C1769 Guide wire <1% 963 $289.58
J3370 Injection, vancomycin hcl, 500 mg <1% 1,041 $258.57
80051 <1% 53 $257.04
J0780 Injection, prochlorperazine, up to 10 mg <1% 1,158 $256.28
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,146 $248.66
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,160 $246.85
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 23,221 $244.66
82652 <1% 14 $242.19
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 7,586 $230.52
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 16 $227.67
J0574 Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine <1% 22 $224.94
80175 <1% 20 $224.91
87807 <1% 105 $224.28
83020 <1% 14 $212.93
J1790 Injection, droperidol, up to 5 mg <1% 600 $192.05
82800 <1% 602 $188.68
90460 Immunization administration through 18 years of age via any route, first or only component <1% 138 $164.32
88341 <1% 30 $160.28
88173 <1% 36 $154.43
J3410 Injection, hydroxyzine hcl, up to 25 mg <1% 44 $145.46
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 699 $140.44
J1456 Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg <1% 18 $133.56
73620 <1% 14 $132.71
90694 <1% 22 $132.64
80176 <1% 12 $128.52
96417 <1% 204 $121.95
V5266 Battery for use in hearing device <1% 15 $112.36
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 661 $112.26
80198 <1% 23 $98.58
J3250 Injection, trimethobenzamide hcl, up to 200 mg <1% 25 $91.24
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 244 $88.72
93797 <1% 15 $82.45
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 4,374 $79.13
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 493 $76.91
29125 <1% 157 $66.07
89051 <1% 73 $63.67
90472 Immunization administration, each additional vaccine (list separately) <1% 350 $61.62
J1940 Injection, furosemide, up to 20 mg <1% 568 $59.76
81015 <1% 18 $58.80
86694 <1% 16 $54.02
85384 <1% 49 $39.77
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg <1% 48 $37.20
J2470 Injection, pantoprazole sodium, 40 mg <1% 255 $36.90
80305 <1% 26 $35.53
J1630 Injection, haloperidol, up to 5 mg <1% 134 $33.50
J7605 Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms <1% 134 $24.99
J7050 Infusion, normal saline solution, 250 cc <1% 637 $23.74
Q9957 Injection, perflutren lipid microspheres, per ml <1% 213 $23.40
80145 <1% 21 $21.42
84300 <1% 14 $18.82
J1921 Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg <1% 101 $18.21
J3480 Injection, potassium chloride, per 2 meq <1% 641 $17.99
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 571 $17.69
J3360 Injection, diazepam, up to 5 mg <1% 15 $17.60
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 16 $17.35
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 618 $15.43
83037 <1% 122 $15.04
J1171 Injection, hydromorphone, 0.1 mg <1% 127 $9.93
J3411 Injection, thiamine hcl, 100 mg <1% 26 $8.49
J1939 Injection, bumetanide, 0.5 mg <1% 57 $8.22
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 2,306 $4.81
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 106 $4.78
J1920 Injection, labetalol hydrochloride, 5 mg <1% 176 $4.58
J1836 Injection, metronidazole, 10 mg <1% 61 $4.28
J1596 Injection, glycopyrrolate, 0.1 mg <1% 285 $3.88
Q0243 Injection, casirivimab and imdevimab, 2400 mg <1% 32 $0.27
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 196 $0.25
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 17 $0.15
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 0% 15 $0.00
85576 0% 17 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 973 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 52 $0.00
G0103 Prostate cancer screening; prostate specific antigen test (psa) 0% 183 $0.00
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 0% 51 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 0% 95 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 1,128 $0.00
A4648 Tissue marker, implantable, any type, each 0% 222 $0.00
J2305 Injection, nitroglycerin, 5 mg 0% 19 $0.00
C9399 Unclassified drugs or biologicals 0% 72 $0.00
A9585 Injection, gadobutrol, 0.1 ml 0% 29 $0.00
95012 0% 18 $0.00
96411 0% 18 $0.00
00790 0% 25 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 434 $0.00
85347 0% 175 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 14 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 76 $0.00
00812 0% 61 $0.00
A9577 Injection, gadobenate dimeglumine (multihance), per ml 0% 127 $0.00
C1729 Catheter, drainage 0% 76 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 15 $0.00
00400 0% 34 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 66 $0.00
G0330 Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room 0% 14 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSEMINARO, ANTHONY (CFO YOUNGSTOWN)
Same official

Other billing entities under SEMINARO, ANTHONY

Full network →
ProviderLocationPaid
Mercy Health Youngstown LLCGirard, OH$3.75M
Mercy Health Youngstown LLCYoungstown, OH$707K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.